AGILENT TECHNOLOGIES, INC. is 4.6x more valuable than Bio-Rad Laboratories, Inc. by market capitalization ($37.20 B vs $8.09 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | A | BIO |
|---|---|---|
| Market cap | $37.20 B | $8.09 B |
| US-listed rank | #403 | #1065 |
| Revenue (latest FY) | $6.95B | $2.58B |
| Net income (latest FY) | $1.30B | $759.90M |
| Net margin | 18.8% | 29.4% |
| P/E (trailing FY) | 28.5 | 10.6 |
| SEC filings | 2,339 | 1,494 |
AGILENT TECHNOLOGIES, INC. is 4.6x more valuable than Bio-Rad Laboratories, Inc. by market capitalization ($37.20 B vs $8.09 B).
In their latest fiscal years, AGILENT TECHNOLOGIES, INC. reported $6.95B in revenue while Bio-Rad Laboratories, Inc. reported $2.58B.
Full pages: AGILENT TECHNOLOGIES, INC. and Bio-Rad Laboratories, Inc., or browse the full rankings.